Polymer–drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic
- 1 July 2001
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 74 (1-3) , 135-146
- https://doi.org/10.1016/s0168-3659(01)00328-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Amphoteric Linear Poly(amido-amine)s as Endosomolytic Polymers: Correlation between Physicochemical and Biological PropertiesMacromolecules, 2000
- Dendrimer-platinateAnti-Cancer Drugs, 1999
- Poly(amidoamine)s as Potential Endosomolytic Polymers: EvaluationIn Vitroand Body Distribution in Normal and Tumour-Bearing AnimalsJournal of Drug Targeting, 1999
- Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal TissuesJapanese Journal of Cancer Research, 1998
- Drug Delivery Systems. 2. Camptothecin 20-O-Poly(ethylene glycol) Ester Transport FormsJournal of Medicinal Chemistry, 1996
- Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrierEuropean Journal Of Cancer, 1995
- Drug-polymer conjugatesAnti-Cancer Drugs, 1992
- Preclinical evaluation of polymer-bound doxorubicinJournal of Controlled Release, 1992
- Degradation of side-chains of N-(2-hydroxypropyl)methacrylamide copolymers by lysosomal thiol-proteinasesBioscience Reports, 1982
- Structure and properties of pharmacologically active polymersJournal of Polymer Science: Polymer Symposia, 1975